Literature DB >> 33670168

Precision Surgery and Kidney Cancer: Knowledge of Genetic Alterations Influences Surgical Management.

Patrick T. Gomella1, W. Marston Linehan1, Mark W. Ball1.   

Abstract

Renal cell carcinoma is a term that represents multiple different disease processes, each driven by different genetic alterations, with distinct histology, and biological potential which necessitates divergent management strategies. This review discusses the genetic alterations seen in several forms of hereditary kidney cancer and how that knowledge can dictate when and how to intervene with a focus on the surgical management of these tumors.

Entities:  

Keywords:  Birt-Hogg-Dubé; Von Hippel-Lindau; genetic alterations; hereditary leiomyomatosis and renal cell cancer; kidney cancer; precision surgery; renal cell carcinoma

Year:  2021        PMID： 33670168      PMCID： PMC7916897          DOI： 10.3390/genes12020261

Source DB:  PubMed          Journal:  Genes (Basel)        ISSN： 2073-4425            Impact factor:   4.096


  51 in total

1.  Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products.

Authors:  M van Slegtenhorst; M Nellist; B Nagelkerken; J Cheadle; R Snell; A van den Ouweland; A Reuser; J Sampson; D Halley; P van der Sluijs
Journal:  Hum Mol Genet       Date:  1998-06       Impact factor: 6.150

2.  Inherited susceptibility to uterine leiomyomas and renal cell cancer.

Authors:  V Launonen; O Vierimaa; M Kiuru; J Isola; S Roth; E Pukkala; P Sistonen; R Herva; L A Aaltonen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

Review 3.  Inherited kidney cancer syndromes.

Authors:  Mark W Ball; Brian M Shuch
Journal:  Curr Opin Urol       Date:  2019-07       Impact factor: 2.309

4.  Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34.

Authors:  M van Slegtenhorst; R de Hoogt; C Hermans; M Nellist; B Janssen; S Verhoef; D Lindhout; A van den Ouweland; D Halley; J Young; M Burley; S Jeremiah; K Woodward; J Nahmias; M Fox; R Ekong; J Osborne; J Wolfe; S Povey; R G Snell; J P Cheadle; A C Jones; M Tachataki; D Ravine; J R Sampson; M P Reeve; P Richardson; F Wilmer; C Munro; T L Hawkins; T Sepp; J B Ali; S Ward; A J Green; J R Yates; J Kwiatkowska; E P Henske; M P Short; J H Haines; S Jozwiak; D J Kwiatkowski
Journal:  Science       Date:  1997-08-08       Impact factor: 47.728

5.  Parenchymal sparing surgery in patients with hereditary renal cell carcinoma: 10-year experience.

Authors:  J C Herring; E G Enquist; A Chernoff; W M Linehan; P L Choyke; M M Walther
Journal:  J Urol       Date:  2001-03       Impact factor: 7.450

6.  CDC73 Germline Mutation in a Family With Mixed Epithelial and Stromal Tumors.

Authors:  Cathy D Vocke; Christopher J Ricketts; Mark W Ball; Laura S Schmidt; Adam R Metwalli; Lindsay A Middelton; J Keith Killian; Javed Khan; Paul S Meltzer; William F Simonds; Maria J Merino; W Marston Linehan
Journal:  Urology       Date:  2018-11-16       Impact factor: 2.649

7.  Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé syndrome.

Authors:  Michael L Nickerson; Michelle B Warren; Jorge R Toro; Vera Matrosova; Gladys Glenn; Maria L Turner; Paul Duray; Maria Merino; Peter Choyke; Christian P Pavlovich; Nirmala Sharma; McClellan Walther; David Munroe; Rob Hill; Eamonn Maher; Cheryl Greenberg; Michael I Lerman; W Marston Linehan; Berton Zbar; Laura S Schmidt
Journal:  Cancer Cell       Date:  2002-08       Impact factor: 31.743

8.  Cutaneous leiomyomata with uterine leiomyomata.

Authors:  W B Reed; R Walker; R Horowitz
Journal:  Acta Derm Venereol       Date:  1973       Impact factor: 4.437

Review 9.  Hereditary papillary renal cell carcinoma: clinical studies in 10 families.

Authors:  B Zbar; G Glenn; I Lubensky; P Choyke; M M Walther; G Magnusson; U S Bergerheim; S Pettersson; M Amin; K Hurley
Journal:  J Urol       Date:  1995-03       Impact factor: 7.450

10.  Germline BAP1 mutations predispose to malignant mesothelioma.

Authors:  Joseph R Testa; Mitchell Cheung; Jianming Pei; Jennifer E Below; Yinfei Tan; Eleonora Sementino; Nancy J Cox; A Umran Dogan; Harvey I Pass; Sandra Trusa; Mary Hesdorffer; Masaki Nasu; Amy Powers; Zeyana Rivera; Sabahattin Comertpay; Mika Tanji; Giovanni Gaudino; Haining Yang; Michele Carbone
Journal:  Nat Genet       Date:  2011-08-28       Impact factor: 38.330
View more
  2 in total

1.  X-Capsular Incision for Tumor Enucleation (X-CITE)-Technique: A Method to Maximize Renal Parenchymal Preservation for Completely Endophytic Renal Tumors.

Authors:  Amir H Lebastchi; Brittnee Haynes; Sandeep Gurram; Gennady Bratslavsky; Adam R Metwalli; W Marston Linehan; Mark W Ball
Journal:  Urology       Date:  2021-04-05       Impact factor: 2.633

Review 2.  A 25 year perspective on the evolution and advances in an understanding of the biology, evaluation and treatment of kidney cancer.

Authors:  Daniel M Geynisman; Jodi K Maranchie; Mark W Ball; Gennady Bratslavsky; Eric A Singer
Journal:  Urol Oncol       Date:  2021-06-04       Impact factor: 2.954
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.